SEC Filing Analysis: Nyxoah SA (NYXH)

Executive Summary

• Trading Significance: High
• Key Takeaway: Major institutional holder Cochlear Ltd significantly increased its stake in Nyxoah SA by purchasing over 0.5% of the company's outstanding shares, bringing its total ownership to 13.59%.
• Market Impact: This transaction is a strong vote of confidence from a strategic investor during a public offering, which is a positive signal despite the dilutive nature of the offering itself.

Company Information

Field	Value
Company	Nyxoah SA
Ticker Symbol	NYXH (Not in filing)
CIK	0001857190
Industry	Surgical & Medical Instruments & Apparatus

Insider Information

Field	Value
Name	Cochlear Ltd
CIK	0001870044
Title/Position	Not Applicable
Relationship	10% Owner

Transaction Details

Field	Value
Form Type	SCHEDULE 13D/A
Transaction Date	2025-11-20
Transaction Code	Not Applicable
Security Type	Ordinary Shares
Shares Involved	215,964
Price Per Share	Not Available
Total Value	Not Available
Shares Owned After	5,847,283
Ownership Type	Indirect

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	Not Available
% of Market Cap	Not Available
Shares Transacted	215,964
% of Shares Outstanding	0.50%
Post-Transaction Ownership	5,847,283 shares (13.59% of outstanding)
Materiality Assessment	Highly Significant

Impact Evaluation

• Market Cap Context: For Nyxoah SA, a small-cap company with a $190 million market capitalization, an acquisition of this share volume is noteworthy.
• Ownership Concentration: Cochlear's 13.59% stake represents a significant concentration of ownership. This purchase further solidifies its position as a key stakeholder.
• Transaction Significance: The acquisition of 0.50% of the company's total outstanding shares in a single transaction crosses the 0.5% threshold for high significance. It indicates strong conviction from Cochlear Ltd, especially as it was part of a public offering.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: While a large purchase from a major holder is a bullish signal, it occurred within the context of a dilutive public offering. The net effect is likely neutral as the market absorbs the new shares, though the vote of confidence is a clear positive.

Volume & Sentiment

• Expected Volume Impact: The public offering itself will create a volume spike. This filing confirms the identity of a major buyer within that event.
• Sentiment Indicator: Neutral to slightly Bullish. The confidence shown by Cochlear provides a bullish counterpoint to the dilution from the offering.

Investment Insights

Positive Market Indicators

• Strong Shareholder Support: A major, strategic shareholder (Cochlear) participated in a public offering, signaling strong belief in the company's prospects.
• Material Increase in Stake: The purchase was significant relative to the total shares outstanding, demonstrating high conviction.

Risk Factors

• Share Dilution: The transaction was part of a public offering, which is dilutive to existing shareholders.
• Ownership Concentration: While a sign of confidence, a high ownership concentration also poses a risk if the major holder decides to sell a large portion of its stake in the future.

Key Takeaways

1. Cochlear Ltd materially increased its stake in Nyxoah SA, reinforcing its position as a key strategic investor.
2. The purchase of 0.50% of total shares outstanding is a highly significant event, indicating strong institutional conviction.
3. This action provides a strong vote of confidence in Nyxoah SA, particularly as it occurred during a capital-raising event.

Additional Context

Transaction Notes

• The purchase was executed as part of Nyxoah SA's public offering of Ordinary Shares, as detailed in the prospectus supplement from November 13, 2025.